CHADDS FORD, Pa., Jan. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings, Inc. , a market leader in pain management, will hold a conference call for the financial community at 5:00 p.m. ET today to discuss its financial guidance for 2006. The company expects to issue a press release announcing its guidance at approximately 4:00 p.m. ET today prior to the conference call.
Peter A. Lankau, president and chief executive officer, and Jeffrey R. Black, executive vice president and chief financial officer, will host the call.
Investors and other interested parties may access the conference call as follows:
Telephone Numbers (800) 305-2862 (domestic/Canada) (706) 634-1979 (international)
Please dial in 10 minutes prior to the scheduled start time, and reference passcode 4156450.
A replay of the call will be available from January 9, 2006 at 7:00 p.m. ET by dialing (800) 642-1687 (domestic/Canada) or (706) 645-9291 (international), passcode 4156450, and will run until 12:00 a.m. ET on January 16, 2006.
A simultaneous webcast of the call for interested investors and others may be accessed by visiting http://www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on January 16, 2006. The replay can be accessed by clicking on “Events” in the Investor Relations section of the web site.
Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at http://www.endo.com.
CONTACT: Bill Newbould Endo Pharmaceuticals (610) 558-9800
Endo Pharmaceuticals Holdings, Inc.
CONTACT: Bill Newbould of Endo Pharmaceuticals, +1-610-558-9800
Web site: http://www.endo.com/
